It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Recognizing warning signs of bad budgeting practices is essential for financial health. Learn what to look out for to stay on track.
10,973 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Tech insiders are stepping up their open-market purchases in software, chipmakers, and AI platforms, reviving a contr...
The first half of 2026 handed investors a harsh lesson on how fast sentiment can turn in ad tech. This article breaks...
Jim Cramer has spotlighted a widening valuation gap between NVIDIA and SanDisk, calling it the 'most insulting trade'...
Tech stocks retreat as geopolitical tensions escalate and oil climbs, sending the live nasdaq composite: tech lower a...
Turning 65 brings decisions about Social Security and Medicare. This guide breaks down three essential facts to help ...
Pi Network’s price down again? PI teeters at a fresh floor as unlocks approach and market skepticism grows. Analysts ...
When a pharma giant pays more than double a target’s value, the move sends shockwaves through investors. This article...
Pi Network surged 10% in a 24-hour window, reviving debate over a possible bottom. Analysts are weighing network pric...
A new forecast from the most powerful claude model signals a substantial Solana rally by year-end 2026, backed by ris...
A prominent crypto researcher questions whether using iphone safer than a hardware wallet for signing transactions, f...
Investors await Intuitive Surgical’s Q2 release after a sharp YTD decline. Live updates will track da Vinci growth, u...